For medtech leaders, six actions are key to turning their tariffs response into a competitive advantage.
Education
- PhD, structural engineering, Northwestern University
- MSc, civil engineering, University of Tokyo
- MSc, civil engineering, Polytechnic University of Milan
- BS, civil engineering, Polytechnic University of Milan
Michele Brocca is the global leader for medtech operations and a core member of the Operations, Health Care, and Transaction and Integration Excellence practices at Boston Consulting Group.
Since joining BCG in 2000, Michele has worked with clients across a range of industries, including health care, industrial goods, and consumer goods.
Michele believes that in large-scale programs such as post-merger integrations, supply chain transformations, and productivity and profitability improvement programs, the “who” and “how” are at least as crucial as the “what.” He believes that it is imperative to define not only the solution and the target end state but also the path to get there and the organizational model needed.
Michele’s work is based on the concept that programs that do not address these dimensions adequately will fail to fully capture the opportunity and create sustainable change.
